(Q33934799)

30 July 2017

1 reference

title

Anti-diabetic and toxic effects of vanadium compounds (English)

1 reference

30 July 2017

0 references

Srivastava AK

1

1 reference

30 July 2017

language of work or name

1 reference

1 March 2000

1 reference

Molecular and Cellular Biochemistry

30 July 2017

published in

1 reference

30 July 2017

volume

206

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

177-182

1 reference

Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate.

30 July 2017

cites work

1 reference

12 December 2020

Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV)

1 reference

12 December 2020

The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats

1 reference

12 December 2020

Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats

1 reference

12 December 2020

Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats

1 reference

12 December 2020

Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats

1 reference

12 December 2020

Vanadium and diabetes

1 reference

12 December 2020

Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle

1 reference

12 December 2020

Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects

1 reference

12 December 2020

The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?

1 reference

12 December 2020

Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle

1 reference

12 December 2020

Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats

1 reference

12 December 2020

Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV)

1 reference

12 December 2020

Oral vanadyl sulfate in treatment of diabetes mellitus in rats

1 reference

12 December 2020

Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used

1 reference

12 December 2020

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effects of vanadium on glucose metabolism

1 reference

12 December 2020

Oral administration of vanadate to streptozotocin-diabetic rats restores the glucose-induced activation of liver glycogen synthase

1 reference

12 December 2020

Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats

1 reference

12 December 2020

Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology

1 reference

12 December 2020

Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics

1 reference

12 December 2020

Long-term effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice

1 reference

12 December 2020

Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action

1 reference

12 December 2020

Oral vanadate reduces Na(+)-dependent glucose transport in rat small intestine

1 reference

12 December 2020

Unique and selective mitogenic effects of vanadate on SV40-transformed cells

1 reference

12 December 2020

Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats

1 reference

12 December 2020

Insulinic actions of vanadate in diabetic rats

1 reference

12 December 2020

Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats

1 reference

12 December 2020

In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus

1 reference

12 December 2020

Time course effects of vanadium supplement on cytosolic reduced glutathione level and glutathione S-transferase activity

1 reference

12 December 2020

Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line

1 reference

12 December 2020

Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation.

1 reference

12 December 2020

Bis(maltolato)oxovanadium(IV) is a potent insulin mimic

1 reference

12 December 2020

In vivo insulin resistance in streptozotocin-diabetic rats--evidence for reversal following oral vanadate treatment.

1 reference

12 December 2020

Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.

1 reference

12 December 2020

Beneficial effects of a vanadium complex with cysteine, administered at low doses on benzo(alpha)pyrene-induced leiomyosarcomas in Wistar rats

1 reference

12 December 2020

Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats

1 reference

12 December 2020

Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects

1 reference

12 December 2020

Insulinlike effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats

1 reference

12 December 2020

In vitro and in vivo antineoplastic effects of orthovanadate.

1 reference

12 December 2020

Effects of vanadium on activity and learning in rats.

1 reference

12 December 2020

Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding

1 reference

12 December 2020

Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes

1 reference

12 December 2020

Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats.

1 reference

12 December 2020

Time and dose-response study of the effects of vanadate in rats: changes in blood cells, serum enzymes, protein, cholesterol, glucose, calcium, and inorganic phosphate

1 reference

12 December 2020

Antidiabetic Action of Vanadyl in Rats Independent of in Vivo Insulin-Receptor Kinase Activity

1 reference

12 December 2020

Effects of vanadate on glycolytic enzymes and malic enzyme in insulin-dependent and -independent tissues of diabetic rats

1 reference

12 December 2020

Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats

1 reference

12 December 2020

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1007075204494

1 reference

Dimensions Publication ID

30 July 2017

1030724617

0 references

1 reference